+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Malignant Fibrous Histiocytoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767422
  • Report
  • April 2019
  • Region: Global
  • 55 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • AstraZeneca Plc
  • Bristol-Myers Squibb Co
  • Daiichi Sankyo Co Ltd
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline Plc
  • Italian Sarcoma Group
  • MORE
The global clinical trial report- “2019 Malignant Fibrous Histiocytoma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Malignant Fibrous Histiocytoma. It presents in-depth analysis of Malignant Fibrous Histiocytoma clinical trials across markets and companies. The research work is for providing complete understanding into trends in Malignant Fibrous Histiocytoma.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Malignant Fibrous Histiocytoma clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Malignant Fibrous Histiocytoma

The research work is prepared through extensive and continuous research on Malignant Fibrous Histiocytoma trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Malignant Fibrous Histiocytoma patients are identified
  • The report includes panorama of Malignant Fibrous Histiocytoma clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Malignant Fibrous Histiocytoma clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AstraZeneca Plc
  • Bristol-Myers Squibb Co
  • Daiichi Sankyo Co Ltd
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline Plc
  • Italian Sarcoma Group
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Malignant Fibrous Histiocytoma Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Malignant Fibrous Histiocytoma Clinical Trials by Region
2.2.2 Average Enrollment of Malignant Fibrous Histiocytoma Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Malignant Fibrous Histiocytoma Treatment, 2019

3. Region wise Malignant Fibrous Histiocytoma Clinical Trials
3.1 Asia Pacific Malignant Fibrous Histiocytoma Clinical Trials by Country
3.2 Europe Malignant Fibrous Histiocytoma Clinical Trials by Country
3.3 North America Malignant Fibrous Histiocytoma Clinical Trials by Country
3.4 Middle East and Africa Malignant Fibrous Histiocytoma Clinical Trials by Country
3.5 South and Central America Malignant Fibrous Histiocytoma Clinical Trials by Country

4. Malignant Fibrous Histiocytoma Clinical Trial Trends
4.1 Start Year wise Malignant Fibrous Histiocytoma Clinical Trials
4.2 Phase wise Malignant Fibrous Histiocytoma Clinical Trials
4.3 Trial Status wise Malignant Fibrous Histiocytoma Clinical Trials
4.4 Trial Type wise Malignant Fibrous Histiocytoma Clinical Trials

5. Malignant Fibrous Histiocytoma Average Enrollment Trends
5.1 Average Enrollment in Malignant Fibrous Histiocytoma Trials by Year
5.2 Average Enrollment in Malignant Fibrous Histiocytoma Trials by Phase
5.3 Average Enrollment in Malignant Fibrous Histiocytoma Trials by Status
5.4 Average Enrollment in Malignant Fibrous Histiocytoma Trials by Type of Trial

6. Companies Participating in Malignant Fibrous Histiocytoma Clinical Trials
6.1 Malignant Fibrous Histiocytoma Trials by Sponsor Type
6.2 Malignant Fibrous Histiocytoma Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Malignant Fibrous Histiocytoma Trials- Phase 1
7.2 Malignant Fibrous Histiocytoma Trials- Phase 2
7.3 Malignant Fibrous Histiocytoma Trials- Phase 3
7.4 Malignant Fibrous Histiocytoma Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Malignant Fibrous Histiocytoma Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Malignant Fibrous Histiocytoma Clinical Trials and Enrolment
Figure 5: Europe - Country wise Malignant Fibrous Histiocytoma Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Malignant Fibrous Histiocytoma Clinical Trials and Enrolment
Figure 7: North America - Country wise Malignant Fibrous Histiocytoma Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Malignant Fibrous Histiocytoma Clinical Trials and Enrolment
Figure 9: Malignant Fibrous Histiocytoma Clinical Trials by Phase
Figure 10: Malignant Fibrous Histiocytoma Clinical Trials by Trial Status
Figure 11: Malignant Fibrous Histiocytoma Clinical Trials by Type
Figure 12: Malignant Fibrous Histiocytoma Clinical Trials by Sponsor Type
Figure 13: Malignant Fibrous Histiocytoma Clinical Trials by Leading Sponsors
Figure 14: Malignant Fibrous Histiocytoma Average Enrollment by Phase
Figure 15: Malignant Fibrous Histiocytoma Average Enrollment by Trial Status
Figure 16: Malignant Fibrous Histiocytoma Average Enrollment by Type
Figure 17: Malignant Fibrous Histiocytoma- Average Enrolment by Type of Sponsors
Figure 18: Malignant Fibrous Histiocytoma- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Malignant Fibrous Histiocytoma Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Malignant Fibrous Histiocytoma Clinical Trials and Enrolment
Table 5: Europe - Country wise Malignant Fibrous Histiocytoma Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Malignant Fibrous Histiocytoma Clinical Trials and Enrolment
Table 7: North America - Country wise Malignant Fibrous Histiocytoma Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Malignant Fibrous Histiocytoma Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Malignant Fibrous Histiocytoma Average Enrollment by Phase
Table 15: Malignant Fibrous Histiocytoma Average Enrollment by Trial Status
Table 16: Malignant Fibrous Histiocytoma Average Enrollment by Type
Table 17: Malignant Fibrous Histiocytoma- Average Enrolment by Type of Sponsors
Table 18: Malignant Fibrous Histiocytoma- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3
  • AstraZeneca Plc
  • Bristol-Myers Squibb Co
  • Children’s Cancer and Leukaemia Group
  • Daiichi Sankyo Co Ltd
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline Plc
  • Italian Sarcoma Group
  • Novartis AG
  • Pfizer Inc
  • Threshold Pharmaceuticals Inc
Note: Product cover images may vary from those shown
Adroll
adroll